2024 Q3 Form 10-Q Financial Statement

#000166299124000226 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $69.96M $55.97M
YoY Change 71.28% 60.2%
Cost Of Revenue $12.76M $10.74M
YoY Change 28.43% 35.18%
Gross Profit $57.20M $45.23M
YoY Change 85.06% 67.56%
Gross Profit Margin 81.76% 80.81%
Selling, General & Admin $2.417M $2.522M
YoY Change 10.66% 48.55%
% of Gross Profit 4.23% 5.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $233.3K $247.4K
YoY Change 7.13% 20.02%
% of Gross Profit 0.41% 0.55%
Operating Expenses $2.417M $2.522M
YoY Change 10.66% 48.55%
Operating Profit $20.84M $16.70M
YoY Change 289.57% 343.74%
Interest Expense -$3.328M -$2.911M
YoY Change -180.32% -174.01%
% of Operating Profit -15.97% -17.43%
Other Income/Expense, Net $96.06K $50.13K
YoY Change 559.73% -95.35%
Pretax Income $17.61M $13.58M
YoY Change 1243.93% 1070.27%
Income Tax $2.163M -$16.12M
% Of Pretax Income 12.28% -118.74%
Net Earnings $15.45M $29.70M
YoY Change 1093.31% 2505.94%
Net Earnings / Revenue 22.08% 53.07%
Basic Earnings Per Share $2.79 $5.25
Diluted Earnings Per Share $2.62 $4.93
COMMON SHARES
Basic Shares Outstanding 5.600M shares 5.667M shares
Diluted Shares Outstanding 5.906M shares 6.024M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.06M $58.03M
YoY Change 22.89% -6.54%
Cash & Equivalents $80.06M $58.03M
Short-Term Investments
Other Short-Term Assets $15.75M $12.19M
YoY Change 144.29% 150.18%
Inventory
Prepaid Expenses
Receivables $132.8M $119.2M
Other Receivables $3.823M $1.024M
Total Short-Term Assets $232.4M $190.5M
YoY Change 31.91% 24.75%
LONG-TERM ASSETS
Property, Plant & Equipment $834.1K $865.4K
YoY Change 401.68% 321.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $347.5K $402.4K
YoY Change -45.03% -42.0%
Total Long-Term Assets $20.44M $21.61M
YoY Change 452.43% 733.06%
TOTAL ASSETS
Total Short-Term Assets $232.4M $190.5M
Total Long-Term Assets $20.44M $21.61M
Total Assets $252.9M $212.1M
YoY Change 40.56% 36.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.45M $71.25M
YoY Change 3.32% 5.68%
Accrued Expenses $11.48M $8.440M
YoY Change 46.5% 68.07%
Deferred Revenue $4.373M $3.942M
YoY Change 111.25% 118.66%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $96.88M $91.95M
YoY Change 16.11% 16.87%
LONG-TERM LIABILITIES
Long-Term Debt $93.94M $68.88M
YoY Change 24.61% 19.53%
Other Long-Term Liabilities $59.68K $74.07K
YoY Change -96.06% -96.33%
Total Long-Term Liabilities $59.68K $74.07K
YoY Change -96.06% -96.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $96.88M $91.95M
Total Long-Term Liabilities $59.68K $74.07K
Total Liabilities $191.7M $161.8M
YoY Change 18.4% 16.39%
SHAREHOLDERS EQUITY
Retained Earnings -$115.1M -$126.0M
YoY Change -28.24% -22.13%
Common Stock $2.084K $2.084K
YoY Change -0.05% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.14M $50.29M
YoY Change
Total Liabilities & Shareholders Equity $252.9M $212.1M
YoY Change 40.56% 36.58%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $15.45M $29.70M
YoY Change 1093.31% 2505.94%
Depreciation, Depletion And Amortization $233.3K $247.4K
YoY Change 7.13% 20.02%
Cash From Operating Activities $5.710M -$4.395M
YoY Change -143.42% -167.09%
INVESTING ACTIVITIES
Capital Expenditures $284.0K $434.1K
YoY Change -4.74% 3.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$284.0K -$434.1K
YoY Change -4.74% 3.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 18.83M -13.28M
YoY Change 9.14% 380.32%
NET CHANGE
Cash From Operating Activities 5.710M -4.395M
Cash From Investing Activities -284.0K -434.1K
Cash From Financing Activities 18.83M -13.28M
Net Change In Cash 24.25M -18.11M
YoY Change 537.95% -637.68%
FREE CASH FLOW
Cash From Operating Activities $5.710M -$4.395M
Capital Expenditures $284.0K $434.1K
Free Cash Flow $5.426M -$4.829M
YoY Change -140.35% -178.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Revenues
Revenues
55968505 usd
CY2023Q2 us-gaap Revenues
Revenues
34937665 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12736523 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12017071 usd
CY2024Q2 szl Transaction Expense
TransactionExpense
10741618 usd
CY2023Q2 szl Transaction Expense
TransactionExpense
7945948 usd
CY2024Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2180233 usd
CY2023Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1903630 usd
CY2024Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
995089 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3313662 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
39269125 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
31174374 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16699380 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3763291 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50127 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1078753 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-251706 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1627120 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2521782 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1697629 usd
CY2024Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
10093880 usd
CY2023Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4296434 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13578668 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1160304 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16123213 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20526 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1139778 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-75402 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
304687 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29626479 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1444465 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.25
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.93
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5660196 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5579618 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5655741 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
50289715 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
128689 shares
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
7258600 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5755961 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-720950 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-646999 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125961197 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157519880 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
50289715 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22094324 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212076653 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212645283 usd
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02631579
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2024#AccountingStandardsUpdate201613Member
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02631579
szl Financing Receivable Installment Payment Plan Installment Period
FinancingReceivableInstallmentPaymentPlanInstallmentPeriod
P14D
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02631579
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5745665 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5826206 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5584986 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5697517 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2084 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2085 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
184228378 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186015079 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
160679 shares
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2911133 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3933446 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-259706 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
29701881 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6024378 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8843246 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2697156 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12469 usd
szl Stock Issued During Period Value Restricted Stock Units Vested In Period
StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod
2128882 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1305389 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
158879 usd
us-gaap Net Income Loss
NetIncomeLoss
2864324 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16278144 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22094324 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
237519 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
33400 usd
szl Stock Issued During Period Value Restricted Stock Units Vested In Period
StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod
740133 usd
szl Stock Issued During Period Value Stock Subscriptions Collectable On Options Exercised
StockIssuedDuringPeriodValueStockSubscriptionsCollectableOnOptionsExercised
0 usd
szl Stock Issued During Period Value Stock Subscriptions Collected On Options Exercised
StockIssuedDuringPeriodValueStockSubscriptionsCollectedOnOptionsExercised
38848 usd
szl Adjustments To Additional Paid In Capital Conversion Of Warrant Liability To Stockholders Equity
AdjustmentsToAdditionalPaidInCapitalConversionOfWarrantLiabilityToStockholdersEquity
2228813 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
12842738 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1502639 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-73951 usd
us-gaap Net Income Loss
NetIncomeLoss
37708886 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13662501 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
549071 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11719 usd
CY2023Q2 szl Stock Issued During Period Value Restricted Stock Units Vested In Period
StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod
1886859 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1276471 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
304687 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1139778 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16278144 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
29613391 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
870091 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65703 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
33400 usd
CY2024Q2 szl Stock Issued During Period Value Restricted Stock Units Vested In Period
StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod
591918 usd
CY2024Q2 szl Stock Issued During Period Value Stock Subscriptions Collected On Options Exercised
StockIssuedDuringPeriodValueStockSubscriptionsCollectedOnOptionsExercised
38848 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9361661 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1188454 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-75402 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
29701881 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
50289715 usd
us-gaap Net Income Loss
NetIncomeLoss
37708886 usd
us-gaap Net Income Loss
NetIncomeLoss
2864324 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
474199 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
406879 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
15233846 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5990798 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
2598863 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1150042 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2367253 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4826038 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
314927 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
351566 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1261556 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
168495 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
47963 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
27838 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
12052 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-45635 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-259706 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-16844980 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
4140242 usd
us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-4646736 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2051996 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
573618 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1177339 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1199423 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2553554 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15782344 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2735588 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
272680 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3347639 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3412280 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1299377 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
286595 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
43898 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
7404 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34218260 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2476211 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25784 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76350 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
748358 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
663208 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-774142 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-739558 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
46726901 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
11300000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
71726901 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
18000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1005102 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
52883 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
237519 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12469 usd
szl Proceeds From Collection Of Stock Subscriptions Related To Stock Option Exercises
ProceedsFromCollectionOfStockSubscriptionsRelatedToStockOptionExercises
38848 usd
szl Proceeds From Collection Of Stock Subscriptions Related To Stock Option Exercises
ProceedsFromCollectionOfStockSubscriptionsRelatedToStockOptionExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
33400 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14345377 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1305389 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40040712 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8045803 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-110210 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175714 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6596594 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6309150 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70699223 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69522658 usd
szl Noncash Or Part Noncash Acquisition Conversion Of Warrant Liabilities To Stockholders Equity
NoncashOrPartNoncashAcquisitionConversionOfWarrantLiabilitiesToStockholdersEquity
2228813 usd
szl Noncash Or Part Noncash Acquisition Conversion Of Warrant Liabilities To Stockholders Equity
NoncashOrPartNoncashAcquisitionConversionOfWarrantLiabilitiesToStockholdersEquity
0 usd
us-gaap Interest Paid Net
InterestPaidNet
7148619 usd
us-gaap Interest Paid Net
InterestPaidNet
7682014 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1526817 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
72599 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation format. These reclassifications had no effect on our total assets, net income, or total comprehensive income.</span></div>
CY2024Q2 us-gaap Revenues
Revenues
55968505 usd
CY2023Q2 us-gaap Revenues
Revenues
34937665 usd
us-gaap Revenues
Revenues
102947139 usd
us-gaap Revenues
Revenues
69611096 usd
CY2024Q2 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
25779438 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30189067 usd
CY2024Q2 us-gaap Revenues
Revenues
55968505 usd
CY2023Q2 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
23481508 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11456157 usd
CY2023Q2 us-gaap Revenues
Revenues
34937665 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
47512039 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55435100 usd
us-gaap Revenues
Revenues
102947139 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
47700258 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21910838 usd
us-gaap Revenues
Revenues
69611096 usd
CY2024Q2 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3149888 usd
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3340150 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3942120 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2643230 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2550489 usd
szl Consumer Installment Payment Plans Number Of Installments
ConsumerInstallmentPaymentPlansNumberOfInstallments
4 installment
szl Financing Receivables Receivables Due Duration
FinancingReceivablesReceivablesDueDuration
P42D
CY2024Q2 szl Number Of Product Segments
NumberOfProductSegments
1 product
CY2024Q2 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
134171362 usd
CY2023Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
146225832 usd
CY2024Q2 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3149888 usd
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3340150 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
131021474 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
142885682 usd
szl Financing Receivable Excluding Accrued Interest Weighted Average Days Outstanding
FinancingReceivableExcludingAccruedInterestWeightedAverageDaysOutstanding
P34D
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
130821023 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
200451 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
131021474 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
142882717 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
2965 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
142885682 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
131021474 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
142885682 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
9182732 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6251765 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
12253041 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
10223451 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
10093880 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4296434 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
15233846 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
5990798 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
8199501 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
5058431 usd
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
17226509 usd
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
11177441 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
709030 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
1004324 usd
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
1525763 usd
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
2335861 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
11786141 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6494092 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
11786141 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6494092 usd
us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
4542974 usd
us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
12676826 usd
us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
6232 usd
us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
477 usd
us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
0 usd
us-gaap Financing Receivable Excluding Accrued Interest Revolving Writeoff
FinancingReceivableExcludingAccruedInterestRevolvingWriteoff
17226509 usd
szl Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearRecoveries
2082 usd
szl Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearRecoveries
962040 usd
szl Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearRecoveries
269584 usd
szl Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearRecoveries
227353 usd
szl Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearRecoveries
64704 usd
szl Financing Receivable Excluding Accrued Interest Revolving Recoveries
FinancingReceivableExcludingAccruedInterestRevolvingRecoveries
1525763 usd
szl Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteOffRecoveriesNet
4540892 usd
szl Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteOffRecoveriesNet
11714786 usd
szl Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteOffRecoveriesNet
-263352 usd
szl Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteOffRecoveriesNet
-226876 usd
szl Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteOffRecoveriesNet
-64704 usd
szl Financing Receivable Excluding Accrued Interest Revolving Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestRevolvingWriteOffRecoveriesNet
15700746 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1023752 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1571728 usd
CY2022Q4 szl Class Of Warrant Or Right Warrant Liabilities Noncurrent
ClassOfWarrantOrRightWarrantLiabilitiesNoncurrent
511295 usd
szl Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
24575 shares
szl Class Of Warrant Or Right Shares Withheld To Cover The Exercise Price
ClassOfWarrantOrRightSharesWithheldToCoverTheExercisePrice
4413 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30035 shares
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16123213 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20526 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15730119 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32150 usd
CY2024Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-16844980 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9693510 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32478033 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
29701881 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1139778 usd
us-gaap Net Income Loss
NetIncomeLoss
37708886 usd
us-gaap Net Income Loss
NetIncomeLoss
2864324 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5660196 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5579618 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5658651 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5529879 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6024378 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5655741 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5980077 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5603919 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.25
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.93
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45448 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
219103 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95896 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
287643 shares
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001662991-24-000226-index-headers.html Edgar Link pending
0001662991-24-000226-index.html Edgar Link pending
0001662991-24-000226.txt Edgar Link pending
0001662991-24-000226-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
szl-20240630.htm Edgar Link pending
szl-20240630.xsd Edgar Link pending
szl-20240630_g1.jpg Edgar Link pending
szl-20240630_cal.xml Edgar Link unprocessable
szl-20240630_def.xml Edgar Link unprocessable
szl-20240630_lab.xml Edgar Link unprocessable
szl-20240630_pre.xml Edgar Link unprocessable
szl-20240630_htm.xml Edgar Link completed